首页> 外文期刊>International journal of hematology >Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations (vol 106, pg 704, 2017)
【24h】

Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations (vol 106, pg 704, 2017)

机译:全长聚乙二醇化重组因子VIII在先前治疗血友病患者中延长半衰期的疗效和安全性A:一般和日本研究人群数据的比较(Vol 106,PG 704,2017)

获取原文
获取原文并翻译 | 示例
           

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号